Jeff Yass’s CAS Medical Systems, Inc. CASM Stock Holding History

Jeff Yass’s Portfolio CASM Stock Details CASM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-22,851	Closed	-$37K	–	10553
2016 Q4	$37K	Buy	+22,851	New	+$38.4K	﹤0.01%	9351

Other funds holding CASM

ACP

Acuta Capital Partners Redwood City, California $143M AUM 773.18% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

1CM

1492 Capital Management Milwaukee, Wisconsin $339M AUM 120.53% 1-Year Est. Return

TCM

TD Capital Management Memphis, Tennessee $1.22B AUM 13.44% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

Jeff Yass's CASM Position: Q1 2017 in Review

Jeff Yass sold out of CAS Medical Systems, Inc. (CASM) in Q1 2017, closing a stake of 22,851 shares — an estimated $37K sold.

Jeff Yass first reported a position in CASM in Q4 2016 and held it in 1 quarter. The position peaked at $37K in Q4 2016. 18 funds tracked by Wall St. Rank hold CASM as of Q1 2017.

Jeff Yass reported no remaining CAS Medical Systems, Inc. position as of Q1 2017 after selling out during the quarter.
Jeff Yass sold 22,851 CAS Medical Systems, Inc. shares in Q1 2017, an estimated $37K.
Jeff Yass first reported a position in CAS Medical Systems, Inc. in Q4 2016 and held it in 1 quarter.
Jeff Yass's CAS Medical Systems, Inc. position peaked at $37K in Q4 2016.
18 funds tracked by Wall St. Rank held CAS Medical Systems, Inc. as of Q1 2017.

Based on Susquehanna International Group's 13F filing for Q1 2017, filed 15 May 2017.